Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study

dc.contributor.authorGupta, A
dc.contributor.authorOyekunle, T
dc.contributor.authorSalako, O
dc.contributor.authorDaramola, A
dc.contributor.authorAlatise, O
dc.contributor.authorOgun, G
dc.contributor.authorAdeniyi, A
dc.contributor.authorDeyeaux, A
dc.contributor.authorSaraiya, V
dc.contributor.authorHall, A
dc.contributor.authorAyandipo, O
dc.contributor.authorOlajide, T
dc.contributor.authorOlasehinde, O
dc.contributor.authorArowolo, O
dc.contributor.authorAdisa, A
dc.contributor.authorAfuwape, O
dc.contributor.authorOlusanya, A
dc.contributor.authorAdegoke, A
dc.contributor.authorTollefsbol, T.O
dc.contributor.authorArnett, D
dc.contributor.authorMuehlbauer, M.J
dc.contributor.authorNewgard, C.B
dc.contributor.authorH3 Africa Research Network
dc.contributor.authorAkinyemiju, T
dc.date.accessioned2022-01-02T13:16:43Z
dc.date.available2022-01-02T13:16:43Z
dc.date.issued2021-06-22
dc.descriptionScholarly articlesen_US
dc.description.abstractBreast cancer (BC) in Nigeria is characterized by disproportionately aggressive molecular subtypes. C-reactive protein (CRP) is associated with risk and aggressiveness for several types of cancer. We examined the association of high-sensitivity CRP (hsCRP) with odds of BC by molecular subtype among Nigerian women. Among 296 newly diagnosed BC cases and 259 healthy controls, multivariable logistic regression models were used to estimate adjusted odds ratios (aOR) and 95% confidence intervals (CI) for the association between hsCRP and odds of BC overall and by molecular subtype (luminal A, luminal B, HER2-enriched and triple-negative or TNBC). High hsCRP (> 3 mg/L) was observed in 57% of cases and 31% of controls and was associated with 4 times the odds of BC (aOR: 4.43; 95% CI: 2.56, 7.66) after adjusting for socio-demographic, reproductive, and clinical variables. This association persisted regardless of menopausal status and body mass index (BMI) category. High hsCRP was associated with increased odds of TNBC (aOR: 3.32; 95% CI: 1.07, 10.35), luminal A BC (aOR: 4.03; 95% CI: 1.29, 12.64), and HER2-enriched BC (aOR: 6.27; 95% CI: 1.69, 23.25). Future studies are necessary in this population to further evaluate a potential role for CRP as a predictive biomarker for BC.en_US
dc.identifier.citationGupta A, Oyekunle T, Salako O, Daramola A, Alatise O, Ogun G, Adeniyi A, Deveaux A, Saraiya V, Hall A, Ayandipo O, Olajide T, Olasehinde O, Arowolo O, Adisa A, Afuwape O, Olusanya A, Adegoke A, Tollefsbol TO, Arnett D, Muehlbauer MJ, Newgard CB; H3 Africa Kidney Research Network, Akinyemiju T. Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study. Oncotarget. 2021;12(13):1230-1242. doi: 10.18632/oncotarget.27991 PMID: 34194621; PMCID: PMC8238238en_US
dc.identifier.other10.18632/oncotarget.27991
dc.identifier.urihttps://ir.unilag.edu.ng/handle/123456789/9896
dc.language.isoenen_US
dc.publisherOncotargeten_US
dc.subjectC-reactive proteinen_US
dc.subjectBreast canceren_US
dc.subjectNigeriaen_US
dc.subjectMenopausal statusen_US
dc.subjectResearch Subject Categories::MEDICINE::Surgeryen_US
dc.titleAssociation of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND studyen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype analysis of the MEND study.pdf
Size:
1.42 MB
Format:
Adobe Portable Document Format
Description:
Main article
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: